Skip to main content
Smart Investors Daily
GE

OTC · GENX

Genex Pharmaceutical, Inc.

Healthcare · Drug Manufacturers - Specialty & Generic

$0.00

Up+$0.00 (+0.00%)

Updated Nov 5, 2026, 1:30 PM

SID Score

2.7/10

Composite research score

Smart Money

—

Institutional and insider signal

Market cap
1.79K
P/E ratio
0.01
Dividend yield
0.00%
52-week range
$0.00 – $0.00
Volume
200K
Avg. volume
5.31K

Price performance · GENX

GENX price history

1M range · 1 trading sessions · Daily adjusted prices

Prices through Oct 29, 2026

GENX closed at $0.00 after 1 trading sessions, up 0.00% for the selected period.

No results

At least two price observations are needed to draw this chart.

Latest GENX news

The latest Smart Investors Daily articles mentioning GENX.

GENX research

Overview

Company profile and research snapshot.

Company profile

GENEX PHARMACEUTICAL INC

Analyst outlook

Consensus and target data currently published for this company.

Consensus
—
Average target
—
Implied upside
—
Analysts
—
Open full forecast

News briefing

No generated briefing is available yet.

newsfilecorp.com · Oct 7, 2025

Genix Pharmaceuticals Issues Clarification to Previously Announced Private Placement Terms

Vancouver, British Columbia--(Newsfile Corp. - October 7, 2025) - Genix Pharmaceuticals Corporation (TSXV: GENX) ("GENIX" or the "Company") wishes to clarify an error in its news release dated September 04, 2025 , regarding the Company's recently closed non-brokered private placement. The previous release incorrectly stated that the Units were issued at a price of $0.10 per Unit.

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.